Home/Pipeline/Obexelimab

Obexelimab

Autoimmune Diseases (B cell-mediated)

Phase 3Investigational

Key Facts

Indication
Autoimmune Diseases (B cell-mediated)
Phase
Phase 3
Status
Investigational
Company

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company with a mission to become a leader in autoimmune disease therapies, enabling patients to 'reimagine life.' Led by a veteran team with a proven track record, the company is advancing a pipeline anchored by two late-stage investigational drugs with broad potential across multiple autoimmune indications. Their strategy combines internal development with strategic partnerships and is guided by a set of core values emphasizing transparency, urgency, and innovation.

View full company profile

Therapeutic Areas